Abstracts

Citation

Strong influence of CYP2B6 Genotypic Polymorphisms (Geno) on Efavirenz (EFV) Pharmacokinetics (PK) in HIV-infected (HIV+) Children <3 years of Age: Implications for an EFV Dosing Approach in Young Children.

Citation

Savita G. Pahwa, M.D., Petronella Muresan, M.S., John W. Sleasman, M.D., Terence Fenton, Ed.D., Kimberly Hudgens, MSHCA, M.B.A., Barbara Nowak, B.A., John ( Jack ) Moye, Jr., M.D. Sub-cutaneous interleukin-2 can achieve substantial gains in CD4 counts in HIV-infected pediatric patients who fail to achieve immune reconstitution following HAART. Presented at: 13th Conference on Retroviruses and Opportunistic Infections.

Citation

JH Pilotto, S Brummel, RM Hoffman, P Britto, G Masheto, L Aurpibul, N Chakhtoura, K Klingman, JS Currier. Subsequent pregnancy outcomes in women during follow-up in PROMISE 1077HS. Presented at: CROI 2017; 2017 Feb 16.

Citation

Subtype C HIV-1 Variants Transmitted by Breastfeeding Have Less Glycosylated V2 Loops and Are More Susceptible to V2-Targeted Antibodies PG9 and PG16. Presented at: 20th Conference on Retroviruses and Opportunistic Infections.

Citation

William T. Shearer, M.D., Ph.D., Jaime G. Deville, M.D., Pearl Samson, M.S., John ( Jack ) Moye, Jr., M.D., Courtney V. Fletcher, Pharm.D., Joseph A. Church, M.D., Hans ML Spiegel, M.D., Ph.D., Paul Palumbo, M.D., Terence Fenton, Ed.D., Elizabeth (Betsy) Smith, M.D., Bobbie L. Graham, B.S., William C. Olson, Ph.D. Susceptibility of viral isolates of PACTG protocol 351 to PRO 542 (rCD4-IgG2) and PRO 140 (MAb to CCR5). Presented at: 6th Federation of Clinical Immunology Societies.

Citation

Natasha O. Moraka-Mankge, Gbolahan Ajibola, Melanie Lancien, Jacqueline D. Reeves, Timothy Persyn, Molly Pretorius Holme, Bryan S. Nelson, Michael D. Hughes, Dwight E. Yin, Patrick Jean-Philippe, Kathleen M. Powis, Sikhulile Moyo, Sharon Nachman, Daniel R. Kuritzkes, Mathias Lichterfeld, Roger L. Shapiro. Susceptibility Patterns for VRC07-523LS, PGDM1400LS, and PGT121.414.LS among Children in Botswana. Presented at: CROI 2026; 2025 Feb 23.

Citation

Rupak Shivakoti, Mark Giganti, Michael Lederman, Rachel Ketchum, Sean Brummel, Daniela Moisi, Sufia Dadabhai, Daya Moodley, Avy Violari, Lameck Chinula, Maxensia Owor, Amita Gupta, Judith S. Currier, Taha E Taha, Mary Glenn Fowler, PROMISE study team. Systemic inflammation in pregnant women with HIV: relationship with preterm delivery and HIV treatment regimen. Presented at: International Workshop on HIV Pediatrics; 2023 Jul 24.

Citation

Alejandro Dorenbaum, M.D., John H. Rodman, Pharm.D., Mark Mirochnick, M.D., Jaime Hernandez, M.D. Systemic Pharmacokinetics (PK) Of Oral Zidovudine (ZDV) Given To HIV-1 Infected Pregnant Women During Labor And Delivery.

Citation

T-Cell Activation and Neurodevelopmental Outcomes in Perinatally HIV-Infected Children.

Citation

William Borkowsky, M.D., Ram Yogev, M.D., Petronella Muresan, M.S., Terence Fenton, Ed.D., Elizabeth (Betsy) J. McFarland, M.D., Lisa M. Frenkel, M.D., Edmund Capparelli, Pharm.D., John ( Jack ) Moye, Jr., M.D., Shirley Jankelevich, M.D. T-Cell and virologic outcomes of a progressively increasing structured treatment interruption (STI) study in chronically infected children and adolescents.